S3E05: Beyond Biomarkers: Calling All Data Scientists
Two Scientists Walk Into a Bar
00:00
Is There a Risk of the Unknown?
The cancergino atlas, which was a project sponsor by an i h a decade ago or more, m where the idea was to sequence everybody's tumor types. And now we know that each of those tumor types is actually not one disease, but probably dozens of diseases. The scale of the experiments matters so much, right? I mean, even something as large as the cancer geno matlis, when you divided across 30 nos, more than ten thousand patients, but divided across 30 tumor types.
Play episode from 17:50
Transcript
